BANGKOK, Thailand, Nov 29 (Bernama-AsiaNet) — COLOTECT is a non-invasive colorectal cancer (CRC) self-sampling test that can detect the methylation status of exfoliated cell genes in the intestine, help screen for colorectal cancer and precancerous lesions risk, and detect bowel cancer risk even in the absence of active bleeding lesions, according to BkkGI.
Colorectal cancer is the third most common cancer and the second deadliest cancer globally. In 2020, the number of colorectal cancer diagnoses worldwide was about 1.9 million.
http://mrem.bernama.com/viewsm.php?idm=44853
